Technology
Health
Biotechnology

Idera Pharmaceuticals

$2.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-2.70%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell IDRA and other stocks, options, ETFs, and crypto commission-free!

About IDRA

Idera Pharmaceuticals, Inc. Common Stock, also called Idera Pharmaceuticals, is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. Read More The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.

Employees
36
Headquarters
Exton, Pennsylvania
Founded
1989
Market Cap
70.58M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
226.81K
High Today
$2.60
Low Today
$2.52
Open Price
$2.59
Volume
52.56K
52 Week High
$10.95
52 Week Low
$2.25

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
US
North America

IDRA Earnings

-$0.59
-$0.42
-$0.25
-$0.08
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.